two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir)
You'll see two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir).
That's right...protease inhibitors for hep C.
These are "game changers." They lead to much higher cure rates and shortened treatment duration. They're ADDED to pegylated interferon and ribavirin for genotype 1 hep C.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote